Intake and circulating concentrations of antioxidants in metabolic syndrome

被引：9
作者：
Ford E.S. [1 ]
机构：
[1] Centers for Disease Control and Prevention, Atlanta, GA 30341
来源：
Current Atherosclerosis Reports | 2006年 / 8卷 / 6期
关键词：
Metabolic Syndrome; Lycopene; Irbesartan; Lipoic Acid; Antioxidant Intake;
D O I：
10.1007/s11883-006-0018-8
中图分类号：
学科分类号：
摘要：
Metabolic syndrome, which occurs commonly in populations around the world, has been associated with an increased risk for developing cardiovascular disease and diabetes. Oxidative stress, which has been implicated in the pathogenesis of cardiovascular disease and diabetes, is a common feature of metabolic syndrome. Limited evidence suggests that circulating concentrations of antioxidants are decreased among people with metabolic syndrome. The contributions of reduced consumption and increased utilization of antioxidants leading to increased oxidative stress are largely unknown. People with metabolic syndrome appear to be an attractive group for future research about possible therapeutic options of antioxidants in the medical management of this syndrome. Copyright © 2006 by Current Science Inc.
引用
收藏
页码：448 / 452
页数：4
相关论文
共 57 条
  • [1] Ford E.S., Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S, Diabetes Care, 28, pp. 2745-2749, (2005)
  • [2] Ford E.S., Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: A summary of the evidence, Diabetes Care, 28, pp. 1769-1778, (2005)
  • [3] Lee K.U., Oxidative stress markers in Korean subjects with insulin resistance syndrome, Diabetes Res Clin Pract, 54, SUPPL. 2, (2001)
  • [4] Griendling K.K., FitzGerald G.A., Oxidative stress and cardiovascular injury: Part II: Animal and human studies, Circulation, 108, pp. 2034-2040, (2003)
  • [5] Stephens J.W., Gable D.R., Hurel S.J., Et al., Increased plasma markers of oxidative stress are associated with coronary heart disease in males with diabetes mellitus and with 10-year risk in a prospective sample of males, Clin Chem, 52, pp. 446-452, (2006)
  • [6] Knekt P., Ritz J., Pereira M.A., Et al., Antioxidant vitamins and coronary heart disease risk: A pooled analysis of 9 cohorts, Am J Clin Nutr, 80, pp. 1508-1520, (2004)
  • [7] Baynes J.W., Role of oxidative stress in development of complications in diabetes, Diabetes, 40, pp. 405-412, (1991)
  • [8] Ford E.S., Will J.C., Bowman B.A., Narayan K.M., Diabetes mellitus and serum carotenoids: Findings from the Third National Health and Nutrition Examination Survey, Am J Epidemiol, 149, pp. 168-176, (1999)
  • [9] Salonen J.T., Nyyssonen K., Tuomainen T.P., Et al., Increased risk of non-insulin dependent diabetes mellitus at low plasma vitamin E concentrations: A four year follow up study in men, BMJ, 311, pp. 1124-1127, (1995)
  • [10] Knekt P., Reunanen A., Marniemi J., Et al., Low vitamin E status is a potential risk factor for insulin-dependent diabetes mellitus, J Intern Med, 245, pp. 99-102, (1999)
123456